首页 > 最新文献

Sovremennye Tehnologii v Medicine最新文献

英文 中文
Messenger RNA of FCGR3A and FCGR3B Genes as Monitoring Markers of Clear Cell Renal Adenocarcinoma (a Pilot Study). FCGR3A和FCGR3B基因信使RNA作为透明细胞肾腺癌监测标志物的初步研究
IF 0.6 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 DOI: 10.17691/stm2022.14.3.03
A V Alyasova, Z V Amoev, O O Shkola, D V Novikov, S G Selivanova, V V Novikov

The aim of the study was to assess the capabilities of mRNA genes encoding CD16a (FCGR3A) and CD16b (FCGR3B) in tumor samples from patients with renal cancer, and characterize the tumor process in relation to clinical and morphological factors.

Materials and methods: We used 125 tumor samples from patients with a histologically confirmed diagnosis of renal cancer T1-4N0-1M0-1. A method described by Chomczynski and Sacchi was used to isolate nucleic acids. The mRNA levels were determined using a reverse transcription polymerase chain reaction and calculated according to ΔΔCt formula, taking into account the reaction efficiency.

Results: mRNA of the FCGR3A gene was detected in all tumor tissue samples under study; in contrast, mRNA of the FCGR3B gene was found only in 92.0% (115/125) of cases. In tumors classified as pT1, the mRNA content of the FCGR3A gene was significantly lower than that in tumor samples of pT3 size. There was the significant increase in the mRNA content of both genes with an increase in tumor grade, as well as in the cases with distant metastases. The presence of a tumor thrombus in the inferior vena cava system was accompanied by a significant increase in the mRNA content of the FCGR3A gene.

Conclusion: In tumor tissue samples from patients with clear cell renal cancer, the predominant production of the FCGR3A mRNA was observed in comparison with the FCGR3B mRNA. The revealed relationship of an increased amount of the FCGR3A mRNA and, in some cases, the FCGR3B mRNA with a number of clinical and morphological factors enables to consider the mRNA level of the genes as new monitoring biomarkers.

本研究的目的是评估编码CD16a (FCGR3A)和CD16b (FCGR3B)的mRNA基因在肾癌患者肿瘤样本中的功能,并表征与临床和形态学因素相关的肿瘤过程。材料和方法:我们使用125例组织学诊断为肾癌T1-4N0-1M0-1的患者的肿瘤样本。采用Chomczynski和Sacchi描述的方法分离核酸。采用逆转录聚合酶链反应测定mRNA水平,并考虑反应效率,根据ΔΔCt公式计算mRNA水平。结果:在所研究的所有肿瘤组织样本中均检测到FCGR3A基因mRNA;相比之下,FCGR3B基因mRNA仅在92.0%(115/125)的病例中被发现。在pT1分类的肿瘤中,FCGR3A基因的mRNA含量明显低于pT3大小的肿瘤样本。两种基因的mRNA含量均随肿瘤分级的增加以及远处转移的病例而显著增加。下腔静脉系统肿瘤血栓的存在伴随着FCGR3A基因mRNA含量的显著增加。结论:在透明细胞肾癌患者的肿瘤组织样本中,与FCGR3B mRNA相比,FCGR3A mRNA的表达占优势。研究发现,在某些情况下,FCGR3A mRNA和FCGR3B mRNA的表达量增加与许多临床和形态学因素之间存在关系,因此可以将这些基因的mRNA水平作为新的监测生物标志物。
{"title":"Messenger RNA of <i>FCGR3A</i> and <i>FCGR3B</i> Genes as Monitoring Markers of Clear Cell Renal Adenocarcinoma (a Pilot Study).","authors":"A V Alyasova,&nbsp;Z V Amoev,&nbsp;O O Shkola,&nbsp;D V Novikov,&nbsp;S G Selivanova,&nbsp;V V Novikov","doi":"10.17691/stm2022.14.3.03","DOIUrl":"https://doi.org/10.17691/stm2022.14.3.03","url":null,"abstract":"<p><p><b>The aim of the study</b> was to assess the capabilities of mRNA genes encoding CD16a (<i>FCGR3A</i>) and CD16b (<i>FCGR3B</i>) in tumor samples from patients with renal cancer, and characterize the tumor process in relation to clinical and morphological factors.</p><p><strong>Materials and methods: </strong>We used 125 tumor samples from patients with a histologically confirmed diagnosis of renal cancer T<sub>1-4</sub>N<sub>0-1</sub>M<sub>0-1</sub>. A method described by Chomczynski and Sacchi was used to isolate nucleic acids. The mRNA levels were determined using a reverse transcription polymerase chain reaction and calculated according to ΔΔCt formula, taking into account the reaction efficiency.</p><p><strong>Results: </strong>mRNA of the <i>FCGR3A</i> gene was detected in all tumor tissue samples under study; in contrast, mRNA of the <i>FCGR3B</i> gene was found only in 92.0% (115/125) of cases. In tumors classified as pT1, the mRNA content of the <i>FCGR3A</i> gene was significantly lower than that in tumor samples of pT<sub>3</sub> size. There was the significant increase in the mRNA content of both genes with an increase in tumor grade, as well as in the cases with distant metastases. The presence of a tumor thrombus in the inferior vena cava system was accompanied by a significant increase in the mRNA content of the <i>FCGR3A</i> gene.</p><p><strong>Conclusion: </strong>In tumor tissue samples from patients with clear cell renal cancer, the predominant production of the <i>FCGR3A</i> mRNA was observed in comparison with the <i>FCGR3B</i> mRNA. The revealed relationship of an increased amount of the <i>FCGR3A</i> mRNA and, in some cases, the <i>FCGR3B</i> mRNA with a number of clinical and morphological factors enables to consider the mRNA level of the genes as new monitoring biomarkers.</p>","PeriodicalId":51886,"journal":{"name":"Sovremennye Tehnologii v Medicine","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090913/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9672111","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Study of Biomechanics of the Heart Valve Leaflet Apparatus Using Numerical Simulation Method. 用数值模拟方法研究心脏瓣膜小叶装置的生物力学。
IF 0.6 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 DOI: 10.17691/stm2022.14.2.01
K Yu Klyshnikov, P S Onischenko, Е А Ovcharenko

The aim of the study was to study the complex biomechanics of the aortic valve prosthesis and to analyze the effect of frame mobility on the stress-strain state and geometry of the valve leaflet apparatus using a numerical simulation method, which reproduces the qualitative and quantitative results of its bench tests.

Materials and methods: The object of the study was a commercial valve bioprosthesis UniLine (NeoCor, Russia), a three-dimensional mesh of which was obtained on the basis of computer microtomography with a subsequent analysis of its stress-strain state in the systole- diastole cycle by the finite element method in the Abaqus/CAE medium. The simulation was validated by comparing the results of numerical and bench simulation on the ViVitro Labs hydrodynamic system (ViVitro Labs Inc., Canada).

Results: The method proposed in this study to simulate the mobility of commissural struts by including elastic connectors of adjustable stiffness in the calculation made it possible to reproduce the qualitative effects of the valve leaflet work observed in the bench experiment. The bioprosthetic orifice area in the systolic phase corresponded to the values obtained in the hydrodynamic system throughout the entire systole-diastole cycle. The analysis of the stress-strain state has shown the fundamental difference in the distribution of the von Mises stress fields depending on the numerical experiment design: the concentration of high amplitudes in the area of commissural struts and the central part of the free edge. However, quantitatively, the stress values reached the maximum of 0.850-0.907 MPa (0.141-0.156 MPa on average), which is below the ultimate strength of the biological material.

Conclusion: The results of this study with the validation performed allowed us to conclude that adequate results of modeling the biomechanics of the heart valve leaflet bioprosthesis based on the finite element method can be achieved by using a high-resolution model with the imposition of elastic connectors in the area of commissural struts. Taking into account the mobility of the frame struts of the heart valve prosthesis is decisive in relation to the final geometry of the valve apparatus and can act as a negative factor in case of a highly elastic material of the valve apparatus. The simulation method presented can be used to optimize the leaflet apparatus geometry of heart valve prostheses from the standpoint of assessing the distribution of the stress-strain state.

本研究的目的是研究主动脉瓣假体的复杂生物力学,并采用数值模拟的方法分析框架移动对瓣叶结构的应力-应变状态和几何形状的影响,再现其台架试验的定性和定量结果。材料和方法:研究对象为商业生物瓣膜假体UniLine (NeoCor, Russia),在计算机显微断层扫描的基础上获得其三维网格,随后在Abaqus/CAE介质中通过有限元法分析其在收缩-舒张周期中的应力-应变状态。通过比较ViVitro Labs流体动力系统(ViVitro Labs Inc., Canada)的数值模拟和台架模拟结果,验证了仿真结果。结果:本研究提出的方法通过在计算中加入刚度可调的弹性连接件来模拟连接杆的移动性,从而可以再现在台架实验中观察到的阀叶工作的定性效果。生物假体孔口在收缩期的面积与在整个收缩-舒张周期的流体动力系统中获得的数值相对应。应力-应变状态分析表明,不同数值试验设计下的von Mises应力场分布存在根本差异:高振幅集中在连接支撑区域和自由边缘中心区域。但在定量上,应力值最大为0.850 ~ 0.907 MPa(平均0.141 ~ 0.156 MPa),低于生物材料的极限强度。结论:本研究的结果和验证的执行使我们得出结论,基于有限元法的心脏瓣膜叶生物假体的生物力学建模可以通过在关节支撑区域施加弹性连接器的高分辨率模型来实现。考虑到心脏瓣膜假体的框架支撑的可移动性对于瓣膜装置的最终几何形状是决定性的,并且在瓣膜装置的高弹性材料的情况下可以作为负因素。所提出的仿真方法可以从评估应力-应变状态分布的角度来优化心脏瓣膜假体的小叶器官几何形状。
{"title":"Study of Biomechanics of the Heart Valve Leaflet Apparatus Using Numerical Simulation Method.","authors":"K Yu Klyshnikov,&nbsp;P S Onischenko,&nbsp;Е А Ovcharenko","doi":"10.17691/stm2022.14.2.01","DOIUrl":"https://doi.org/10.17691/stm2022.14.2.01","url":null,"abstract":"<p><p><b>The aim of the study</b> was to study the complex biomechanics of the aortic valve prosthesis and to analyze the effect of frame mobility on the stress-strain state and geometry of the valve leaflet apparatus using a numerical simulation method, which reproduces the qualitative and quantitative results of its bench tests.</p><p><strong>Materials and methods: </strong>The object of the study was a commercial valve bioprosthesis UniLine (NeoCor, Russia), a three-dimensional mesh of which was obtained on the basis of computer microtomography with a subsequent analysis of its stress-strain state in the systole- diastole cycle by the finite element method in the Abaqus/CAE medium. The simulation was validated by comparing the results of numerical and bench simulation on the ViVitro Labs hydrodynamic system (ViVitro Labs Inc., Canada).</p><p><strong>Results: </strong>The method proposed in this study to simulate the mobility of commissural struts by including elastic connectors of adjustable stiffness in the calculation made it possible to reproduce the qualitative effects of the valve leaflet work observed in the bench experiment. The bioprosthetic orifice area in the systolic phase corresponded to the values obtained in the hydrodynamic system throughout the entire systole-diastole cycle. The analysis of the stress-strain state has shown the fundamental difference in the distribution of the von Mises stress fields depending on the numerical experiment design: the concentration of high amplitudes in the area of commissural struts and the central part of the free edge. However, quantitatively, the stress values reached the maximum of 0.850-0.907 MPa (0.141-0.156 MPa on average), which is below the ultimate strength of the biological material.</p><p><strong>Conclusion: </strong>The results of this study with the validation performed allowed us to conclude that adequate results of modeling the biomechanics of the heart valve leaflet bioprosthesis based on the finite element method can be achieved by using a high-resolution model with the imposition of elastic connectors in the area of commissural struts. Taking into account the mobility of the frame struts of the heart valve prosthesis is decisive in relation to the final geometry of the valve apparatus and can act as a negative factor in case of a highly elastic material of the valve apparatus. The simulation method presented can be used to optimize the leaflet apparatus geometry of heart valve prostheses from the standpoint of assessing the distribution of the stress-strain state.</p>","PeriodicalId":51886,"journal":{"name":"Sovremennye Tehnologii v Medicine","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090928/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9310568","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
A Complex of Pyrosequencing-Based Methods for Detection of Somatic Mutations in Codons 600 and 601 of the BRAF gene. 基于焦磷酸测序的BRAF基因600和601密码子体细胞突变检测方法
IF 0.6 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 DOI: 10.17691/stm2022.14.2.04
O P Dribnokhodova, A S Esman, V I Korchagin, A Yu Bukharina, E A Dunaeva, G V Leshkina, E V Borisova, Ya A Voiciehovskaya, A I Daoud, V N Khlyavich, K O Mironov

The aim of the study is to develop methods for the differentiation of mutations in the BRAF codon 600 and to increase the sensitivity of the K601E mutation detection.

Materials and methods: The nucleotide sequence of the BRAF codons 592-602 was identified using the PyroMark Q24 genetic analysis system. The mutations search in codon 600 was conducted using the 600-S primer in line with the following order of adding nucleotides: GCTGTCАTCTGCTAGCTAGAC (corresponding to nucleotides 1799-1786). The K601E mutation was detected using the 601-S primer in line with the following order of nucleotide addition: GCTACTCACTGTAG (corresponding to nucleotides 1801-1793). The analytical characteristics of the proposed methods for somatic mutations' detection were determined using dilutions of plasmid DNA samples containing the BRAF gene region without mutations or with one of the following mutations: V600E, V600R, V600K, V600M, and K601E. Validation was performed on 132 samples of biological material obtained from the thyroid nodules.

Results: The developed methods allow to determine 2% of the V600E or V600M mutations, 1% of the V600K and V600R mutations, and 3% of the K601E mutations in samples with high DNA concentration; it is also possible to confidently detect at least 5% of the mutant allele for all mutations in low concentration samples (less than 500 copies/PCR). During biological material testing, 53 samples with the V600E mutation were detected; the proportion of the mutant allele was 4.9-50.0%.

Conclusion: A complex of methods for determination of the nucleotide sequence of the BRAF codons 592-601 and the algorithm for testing samples and analyzing mutations in the BRAF codons 600-601 was developed. The method provides sufficient sensitivity to detect frequent mutations in codons 600 and 601 and allows them to be precisely differentiated.

本研究的目的是开发BRAF密码子600突变的分化方法,并提高K601E突变检测的灵敏度。材料和方法:BRAF密码子592-602的核苷酸序列采用PyroMark Q24遗传分析系统进行鉴定。使用600- s引物对密码子600进行突变搜索,按照添加核苷酸的顺序依次为GCTGTCАTCTGCTAGCTAGAC(对应核苷酸1799-1786)。使用601-S引物检测K601E突变,核苷酸添加顺序如下:GCTACTCACTGTAG(对应核苷酸1801-1793)。本文提出的体细胞突变检测方法通过稀释含有BRAF基因区域无突变或含有以下突变之一的质粒DNA样品来确定:V600E、V600R、V600K、V600M和K601E。对从甲状腺结节中获得的132个生物材料样本进行了验证。结果:在DNA浓度较高的样品中,所建立的方法可检测2%的V600E或V600M突变,1%的V600K和V600R突变,3%的K601E突变;在低浓度样品(小于500拷贝/PCR)中,也可以自信地检测到至少5%的突变等位基因。在生物材料检测中,检测到53份V600E突变样本;突变等位基因比例为4.9 ~ 50.0%。结论:建立了一套测定BRAF密码子592-601核苷酸序列的方法,以及检测样品和分析BRAF密码子600-601突变的算法。该方法提供了足够的灵敏度来检测密码子600和601的频繁突变,并允许它们精确区分。
{"title":"A Complex of Pyrosequencing-Based Methods for Detection of Somatic Mutations in Codons 600 and 601 of the <i>BRAF</i> gene.","authors":"O P Dribnokhodova,&nbsp;A S Esman,&nbsp;V I Korchagin,&nbsp;A Yu Bukharina,&nbsp;E A Dunaeva,&nbsp;G V Leshkina,&nbsp;E V Borisova,&nbsp;Ya A Voiciehovskaya,&nbsp;A I Daoud,&nbsp;V N Khlyavich,&nbsp;K O Mironov","doi":"10.17691/stm2022.14.2.04","DOIUrl":"https://doi.org/10.17691/stm2022.14.2.04","url":null,"abstract":"<p><p><b>The aim of the study</b> is to develop methods for the differentiation of mutations in the <i>BRAF</i> codon 600 and to increase the sensitivity of the K601E mutation detection.</p><p><strong>Materials and methods: </strong>The nucleotide sequence of the <i>BRAF</i> codons 592-602 was identified using the PyroMark Q24 genetic analysis system. The mutations search in codon 600 was conducted using the 600-S primer in line with the following order of adding nucleotides: GCTGTCАTCTGCTAGCTAGAC (corresponding to nucleotides 1799-1786). The K601E mutation was detected using the 601-S primer in line with the following order of nucleotide addition: GCTACTCACTGTAG (corresponding to nucleotides 1801-1793). The analytical characteristics of the proposed methods for somatic mutations' detection were determined using dilutions of plasmid DNA samples containing the <i>BRAF</i> gene region without mutations or with one of the following mutations: V600E, V600R, V600K, V600M, and K601E. Validation was performed on 132 samples of biological material obtained from the thyroid nodules.</p><p><strong>Results: </strong>The developed methods allow to determine 2% of the V600E or V600M mutations, 1% of the V600K and V600R mutations, and 3% of the K601E mutations in samples with high DNA concentration; it is also possible to confidently detect at least 5% of the mutant allele for all mutations in low concentration samples (less than 500 copies/PCR). During biological material testing, 53 samples with the V600E mutation were detected; the proportion of the mutant allele was 4.9-50.0%.</p><p><strong>Conclusion: </strong>A complex of methods for determination of the nucleotide sequence of the <i>BRAF</i> codons 592-601 and the algorithm for testing samples and analyzing mutations in the <i>BRAF</i> codons 600-601 was developed. The method provides sufficient sensitivity to detect frequent mutations in codons 600 and 601 and allows them to be precisely differentiated.</p>","PeriodicalId":51886,"journal":{"name":"Sovremennye Tehnologii v Medicine","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090924/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9310572","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Selection of the Optimal Method for Creating Various Forms of Biocompatible Xenodermal Materials. 制备各种形式生物相容性异皮材料的最佳方法选择。
IF 0.6 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 Epub Date: 2022-01-28 DOI: 10.17691/stm2022.14.1.04
К I Melkonyan, Y А Kozmai, А А Verevkin, Т V Rusinova, А S Asyakina, М L Zolotavina

The aim of the study was to select the optimal method for creating surgical porcine dermis-based biomaterials and to assess their biological safety.

Materials and methods: To create xenodermal biomaterials, the native skin of a 4-month-old Landrace pig was used. The porcine dermis was processed with saline (protocol No.1), peroxide-alkaline (protocol No.2), and alkaline (protocol No.3) solutions. The obtained samples were stained with hematoxylin-eosin and a DAPI fluorescent dye. Quantitative DNA analysis and assessment of cytotoxicity by the LIVE/DEAD assay were also performed. Samples were implanted/injected subcutaneously to 6-month-old male Wistar rats (n=30) weighing 260±20 g and explanted on day 14 of the experiment. Histological sections were stained with hematoxylin-eosin. Computer morphometry was performed using GraphPad Prism v. 6.04.

Results: Samples of surgical materials obtained according to the three protocols had different physical characteristics: dermis treated according to protocol No.1 was dense and white in color after processing; samples processed by protocol No.2 were transparent and dense, and samples treated according to protocol No.3 had transparent gel-like structures. Histological analysis has shown oxyphilicity and extracellular matrix structure loss in all samples, and DAPI staining has revealed the destruction of cell nuclei. Nevertheless, DNA amount in the samples processed according to protocol No.1 did not meet the established quality criterion for decellularization (50 ng/mg dry weight). Further cytotoxicity assessment in vitro and in vivo was carried out only for samples fabricated according to protocols No.2 and No.3. According to the LIVE/DEAD analysis, both samples were not cytotoxic. On day 14 after the subcutaneous sample implantation, no signs of suppuration and immune rejection were found in the animals.

Conclusion: To obtain surgical materials in the form of bioplastic coatings, it is recommended to use alkaline-peroxide treatment of the dermis, while hydrogel coatings are produced by alkaline hydrolysis.

本研究的目的是选择制备手术用猪真皮基生物材料的最佳方法,并评估其生物安全性。材料与方法:采用4月龄长白猪的天然皮肤制备异种真皮生物材料。猪真皮分别用生理盐水(方案1)、过氧化物碱性溶液(方案2)和碱性溶液(方案3)处理。用苏木精-伊红和DAPI荧光染料对所得样品进行染色。还进行了定量DNA分析和LIVE/DEAD试验的细胞毒性评估。将样品植入/皮下注射于体重260±20 g的6月龄雄性Wistar大鼠(n=30),并于实验第14天取出。组织切片用苏木精-伊红染色。使用GraphPad Prism v. 6.04进行计算机形态测量。结果:三种方案获得的手术材料样品具有不同的物理特征:方案1处理后的真皮层致密,颜色呈白色;方案2处理的样品透明致密,方案3处理的样品具有透明的凝胶状结构。组织学分析显示所有样品的亲氧性和细胞外基质结构丢失,DAPI染色显示细胞核破坏。然而,根据方案1处理的样品中的DNA量不符合既定的脱细胞质量标准(50 ng/mg干重)。进一步的体外和体内细胞毒性评估仅对根据方案2和方案3制备的样品进行。根据LIVE/DEAD分析,两种样品均无细胞毒性。皮下样品植入后第14天,动物未见化脓和免疫排斥现象。结论:为了获得生物塑料涂层形式的手术材料,建议使用碱性过氧化处理真皮,而水凝胶涂层则采用碱性水解制备。
{"title":"Selection of the Optimal Method for Creating Various Forms of Biocompatible Xenodermal Materials.","authors":"К I Melkonyan,&nbsp;Y А Kozmai,&nbsp;А А Verevkin,&nbsp;Т V Rusinova,&nbsp;А S Asyakina,&nbsp;М L Zolotavina","doi":"10.17691/stm2022.14.1.04","DOIUrl":"https://doi.org/10.17691/stm2022.14.1.04","url":null,"abstract":"<p><p><b>The aim of the study</b> was to select the optimal method for creating surgical porcine dermis-based biomaterials and to assess their biological safety.</p><p><strong>Materials and methods: </strong>To create xenodermal biomaterials, the native skin of a 4-month-old Landrace pig was used. The porcine dermis was processed with saline (protocol No.1), peroxide-alkaline (protocol No.2), and alkaline (protocol No.3) solutions. The obtained samples were stained with hematoxylin-eosin and a DAPI fluorescent dye. Quantitative DNA analysis and assessment of cytotoxicity by the LIVE/DEAD assay were also performed. Samples were implanted/injected subcutaneously to 6-month-old male Wistar rats (n=30) weighing 260±20 g and explanted on day 14 of the experiment. Histological sections were stained with hematoxylin-eosin. Computer morphometry was performed using GraphPad Prism v. 6.04.</p><p><strong>Results: </strong>Samples of surgical materials obtained according to the three protocols had different physical characteristics: dermis treated according to protocol No.1 was dense and white in color after processing; samples processed by protocol No.2 were transparent and dense, and samples treated according to protocol No.3 had transparent gel-like structures. Histological analysis has shown oxyphilicity and extracellular matrix structure loss in all samples, and DAPI staining has revealed the destruction of cell nuclei. Nevertheless, DNA amount in the samples processed according to protocol No.1 did not meet the established quality criterion for decellularization (50 ng/mg dry weight). Further cytotoxicity assessment <i>in vitro</i> and <i>in vivo</i> was carried out only for samples fabricated according to protocols No.2 and No.3. According to the LIVE/DEAD analysis, both samples were not cytotoxic. On day 14 after the subcutaneous sample implantation, no signs of suppuration and immune rejection were found in the animals.</p><p><strong>Conclusion: </strong>To obtain surgical materials in the form of bioplastic coatings, it is recommended to use alkaline-peroxide treatment of the dermis, while hydrogel coatings are produced by alkaline hydrolysis.</p>","PeriodicalId":51886,"journal":{"name":"Sovremennye Tehnologii v Medicine","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9376758/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"40717446","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diagnosis of Schizophrenia Based on the Data of Various Modalities: Biomarkers and Machine Learning Techniques (Review). 基于各种模式数据的精神分裂症诊断:生物标志物和机器学习技术(综述)。
IF 0.6 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 DOI: 10.17691/stm2022.14.5.06
M G Sharaev, I K Malashenkova, A V Maslennikova, N V Zakharova, A V Bernstein, E V Burnaev, G S Mamedova, S A Krynskiy, D P Ogurtsov, E A Kondrateva, P V Druzhinina, M O Zubrikhina, A Yu Arkhipov, V B Strelets, V L Ushakov

Schizophrenia is a socially significant mental disorder resulting frequently in severe forms of disability. Diagnosis, choice of treatment tactics, and rehabilitation in clinical psychiatry are mainly based on the assessment of behavioral patterns, socio-demographic data, and other investigations such as clinical observations and neuropsychological testing including examination of patients by the psychiatrist, self-reports, and questionnaires. In many respects, these data are subjective and therefore a large number of works have appeared in recent years devoted to the search for objective characteristics (indices, biomarkers) of the processes going on in the human body and reflected in the behavioral and psychoneurological patterns of patients. Such biomarkers are based on the results of instrumental and laboratory studies (neuroimaging, electro-physiological, biochemical, immunological, genetic, and others) and are successfully being used in neurosciences for understanding the mechanisms of the emergence and development of nervous system pathologies. Presently, with the advent of new effective neuroimaging, laboratory, and other methods of investigation and also with the development of modern methods of data analysis, machine learning, and artificial intelligence, a great number of scientific and clinical studies is being conducted devoted to the search for the markers which have diagnostic and prognostic value and may be used in clinical practice to objectivize the processes of establishing and clarifying the diagnosis, choosing and optimizing treatment and rehabilitation tactics, predicting the course and outcome of the disease. This review presents the analysis of the works which describe the correlates between the diagnosis of schizophrenia, established by health professionals, various manifestations of the psychiatric disorder (its subtype, variant of the course, severity degree, observed symptoms, etc.), and objectively measured characteristics/quantitative indicators (anatomical, functional, immunological, genetic, and others) obtained during instrumental and laboratory examinations of patients. A considerable part of these works has been devoted to correlates/biomarkers of schizophrenia based on the data of structural and functional (at rest and under cognitive load) MRI, EEG, tractography, and immunological data. The found correlates/biomarkers reflect anatomic disorders in the specific brain regions, impairment of functional activity of brain regions and their interconnections, specific microstructure of the brain white matter and the levels of connectivity between the tracts of various structures, alterations of electrical activity in various parts of the brain in different EEG spectral ranges, as well as changes in the innate and adaptive links of immunity. Current methods of data analysis and machine learning to search for schizophrenia biomarkers using the data of diverse modalities and their application during building and i

精神分裂症是一种具有社会意义的精神障碍,经常导致严重形式的残疾。临床精神病学的诊断、治疗策略的选择和康复主要基于对行为模式的评估、社会人口统计数据和其他调查,如临床观察和神经心理测试,包括精神病医生对患者的检查、自我报告和问卷调查。在许多方面,这些数据是主观的,因此近年来出现了大量的工作,致力于寻找人体中正在进行的过程的客观特征(指数,生物标志物),并反映在患者的行为和精神神经模式中。这些生物标志物是基于仪器和实验室研究(神经影像学、电生理、生化、免疫学、遗传学等)的结果,并成功地应用于神经科学,以了解神经系统病理的发生和发展机制。目前,随着新的有效的神经影像学、实验室和其他调查方法的出现,以及现代数据分析、机器学习和人工智能方法的发展,大量的科学和临床研究正在进行,致力于寻找具有诊断和预后价值的标记物,并可用于临床实践,以客观化建立和明确诊断的过程。选择和优化治疗和康复策略,预测疾病的过程和结局。这篇综述分析了一些著作,这些著作描述了精神分裂症的诊断(由卫生专业人员建立)、精神障碍的各种表现(其亚型、病程变异、严重程度、观察到的症状等)与患者在仪器和实验室检查中获得的客观测量特征/定量指标(解剖、功能、免疫、遗传等)之间的相关性。这些工作的相当一部分致力于基于结构和功能(静止和认知负荷下)MRI、EEG、神经束造影和免疫学数据的精神分裂症相关物/生物标志物。所发现的相关物/生物标志物反映了特定脑区的解剖紊乱、脑区功能活动及其相互联系的损害、脑白质的特定微观结构和各种结构束之间的连通性水平、不同脑电图频谱范围内脑各部位电活动的改变,以及免疫先天和适应性环节的变化。目前的数据分析和机器学习方法使用不同模式的数据来搜索精神分裂症生物标志物,以及它们在精神分裂症预测诊断模型的建立和解释中的应用。
{"title":"Diagnosis of Schizophrenia Based on the Data of Various Modalities: Biomarkers and Machine Learning Techniques (Review).","authors":"M G Sharaev,&nbsp;I K Malashenkova,&nbsp;A V Maslennikova,&nbsp;N V Zakharova,&nbsp;A V Bernstein,&nbsp;E V Burnaev,&nbsp;G S Mamedova,&nbsp;S A Krynskiy,&nbsp;D P Ogurtsov,&nbsp;E A Kondrateva,&nbsp;P V Druzhinina,&nbsp;M O Zubrikhina,&nbsp;A Yu Arkhipov,&nbsp;V B Strelets,&nbsp;V L Ushakov","doi":"10.17691/stm2022.14.5.06","DOIUrl":"https://doi.org/10.17691/stm2022.14.5.06","url":null,"abstract":"<p><p>Schizophrenia is a socially significant mental disorder resulting frequently in severe forms of disability. Diagnosis, choice of treatment tactics, and rehabilitation in clinical psychiatry are mainly based on the assessment of behavioral patterns, socio-demographic data, and other investigations such as clinical observations and neuropsychological testing including examination of patients by the psychiatrist, self-reports, and questionnaires. In many respects, these data are subjective and therefore a large number of works have appeared in recent years devoted to the search for objective characteristics (indices, biomarkers) of the processes going on in the human body and reflected in the behavioral and psychoneurological patterns of patients. Such biomarkers are based on the results of instrumental and laboratory studies (neuroimaging, electro-physiological, biochemical, immunological, genetic, and others) and are successfully being used in neurosciences for understanding the mechanisms of the emergence and development of nervous system pathologies. Presently, with the advent of new effective neuroimaging, laboratory, and other methods of investigation and also with the development of modern methods of data analysis, machine learning, and artificial intelligence, a great number of scientific and clinical studies is being conducted devoted to the search for the markers which have diagnostic and prognostic value and may be used in clinical practice to objectivize the processes of establishing and clarifying the diagnosis, choosing and optimizing treatment and rehabilitation tactics, predicting the course and outcome of the disease. This review presents the analysis of the works which describe the correlates between the diagnosis of schizophrenia, established by health professionals, various manifestations of the psychiatric disorder (its subtype, variant of the course, severity degree, observed symptoms, etc.), and objectively measured characteristics/quantitative indicators (anatomical, functional, immunological, genetic, and others) obtained during instrumental and laboratory examinations of patients. A considerable part of these works has been devoted to correlates/biomarkers of schizophrenia based on the data of structural and functional (at rest and under cognitive load) MRI, EEG, tractography, and immunological data. The found correlates/biomarkers reflect anatomic disorders in the specific brain regions, impairment of functional activity of brain regions and their interconnections, specific microstructure of the brain white matter and the levels of connectivity between the tracts of various structures, alterations of electrical activity in various parts of the brain in different EEG spectral ranges, as well as changes in the innate and adaptive links of immunity. Current methods of data analysis and machine learning to search for schizophrenia biomarkers using the data of diverse modalities and their application during building and i","PeriodicalId":51886,"journal":{"name":"Sovremennye Tehnologii v Medicine","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171060/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9675006","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Prognostic Capabilities of Diagnosing Non-Alcoholic Hepatic Steatosis at Early Stages of Its Development. 非酒精性肝脂肪变性早期诊断的预后能力
IF 0.6 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 DOI: 10.17691/stm2022.14.4.03
G I Akhmadullina, I А Kurnikova

The aim of the study is to substantiate the efficacy of new prognostic criteria in diagnosing non-alcoholic hepatic steatosis at early stages of its development.

Materials and methods: Patients with excessive body mass (n=26) and obesity (n=28) having different concomitant pathologies of the digestive organs have undergone a comprehensive examination including assessment of biochemical blood indices, ultrasound examination of the abdominal organs, dynamic hepatobiliscintigraphy, assessment of the comorbidity level as a whole (calculation of CIRS) and by the available pathology of the digestive organs.

Results: The ultrasound signs of hepatic steatosis have been found in all patients with obesity stage II and III, in 69.2% of the examined patients (95% CI: 42.37-87.32) with obesity stage I, in 30.8% (95% CI: 16.50-49.99) with excessive body mass, and in 13.9% of patients (95% CI: 6.08-28.66) with normal body mass. According to the ROC analysis, the predictors of hepatic steatosis development in patients with excessive body mass and obesity are BMI (>31, р<0.0001) and the number of digestive organ illnesses (more than 4 diseases, p<0.0001). On the basis of the data obtained, a logistic model has been developed in the form of the regression equation permitting us to predict the groups of patients with a low or high degree of risk of hepatic steatosis. The analysis of dynamic hepatobiliscintigraphy has revealed deceleration of the absorbing function of hepatocytes in patients with normal ultrasound images of the liver even in case of excessive body mass. The obtained results made it possible to develop a method of diagnosing fatty hepatosis with subsequent calculation of the functional hepatocyte activity index (FHAI) which helps not only establish functional disorders but identify the group of patients having the risk of developing these disorders. Normal ultrasound imaging of the liver and absence of the biochemical changes in the blood are not indicators of preservation of its functional activity, since the risk of functional disorders was found in 32.3% of cases (95% CI: 18.57-49.86) and reversible disorders in 19.3% (95% CI: 9.19-36.28) when FHAI was calculated for patients with normal body mass. With the increase of body mass, irreversible functional disorders of hepatocytes are observed in 80-100% of patients.Thus, the results obtained in the course of the investigation have confirmed the possibility of using new prognostic markers of hepatic steatosis for early diagnosis of non-alcoholic fatty liver disease.

该研究的目的是证实新的预后标准在早期诊断非酒精性肝脂肪变性的有效性。材料和方法:对体重超标(n=26)和肥胖(n=28)合并不同消化器官病理的患者进行综合检查,包括血液生化指标评估、腹部器官超声检查、动态肝胆造影、整体合并症水平评估(计算CIRS),并利用消化器官现有病理。结果:所有肥胖症II期和III期患者均有肝脂肪变性超声征象,肥胖症I期患者中有69.2% (95% CI: 42.37 ~ 87.32)有肝脂肪变性超声征象,体重超标患者中有30.8% (95% CI: 16.50 ~ 49.99)有肝脂肪变性超声征象,体重正常患者中有13.9% (95% CI: 6.08 ~ 28.66)有肝脂肪变性超声征象。根据ROC分析,体重过大和肥胖患者肝脂肪变性发展的预测因子为BMI (>31, >31
{"title":"Prognostic Capabilities of Diagnosing Non-Alcoholic Hepatic Steatosis at Early Stages of Its Development.","authors":"G I Akhmadullina,&nbsp;I А Kurnikova","doi":"10.17691/stm2022.14.4.03","DOIUrl":"https://doi.org/10.17691/stm2022.14.4.03","url":null,"abstract":"<p><p><b>The aim of the study</b> is to substantiate the efficacy of new prognostic criteria in diagnosing non-alcoholic hepatic steatosis at early stages of its development.</p><p><strong>Materials and methods: </strong>Patients with excessive body mass (n=26) and obesity (n=28) having different concomitant pathologies of the digestive organs have undergone a comprehensive examination including assessment of biochemical blood indices, ultrasound examination of the abdominal organs, dynamic hepatobiliscintigraphy, assessment of the comorbidity level as a whole (calculation of CIRS) and by the available pathology of the digestive organs.</p><p><strong>Results: </strong>The ultrasound signs of hepatic steatosis have been found in all patients with obesity stage II and III, in 69.2% of the examined patients (95% CI: 42.37-87.32) with obesity stage I, in 30.8% (95% CI: 16.50-49.99) with excessive body mass, and in 13.9% of patients (95% CI: 6.08-28.66) with normal body mass. According to the ROC analysis, the predictors of hepatic steatosis development in patients with excessive body mass and obesity are BMI (>31, р<0.0001) and the number of digestive organ illnesses (more than 4 diseases, p<0.0001). On the basis of the data obtained, a logistic model has been developed in the form of the regression equation permitting us to predict the groups of patients with a low or high degree of risk of hepatic steatosis. The analysis of dynamic hepatobiliscintigraphy has revealed deceleration of the absorbing function of hepatocytes in patients with normal ultrasound images of the liver even in case of excessive body mass. The obtained results made it possible to develop a method of diagnosing fatty hepatosis with subsequent calculation of the functional hepatocyte activity index (FHAI) which helps not only establish functional disorders but identify the group of patients having the risk of developing these disorders. Normal ultrasound imaging of the liver and absence of the biochemical changes in the blood are not indicators of preservation of its functional activity, since the risk of functional disorders was found in 32.3% of cases (95% CI: 18.57-49.86) and reversible disorders in 19.3% (95% CI: 9.19-36.28) when FHAI was calculated for patients with normal body mass. With the increase of body mass, irreversible functional disorders of hepatocytes are observed in 80-100% of patients.Thus, the results obtained in the course of the investigation have confirmed the possibility of using new prognostic markers of hepatic steatosis for early diagnosis of non-alcoholic fatty liver disease.</p>","PeriodicalId":51886,"journal":{"name":"Sovremennye Tehnologii v Medicine","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171045/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9681404","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modern Rehabilitation Technologies of Patients with Motor Disorders at an Early Rehabilitation of Stroke (Review). 运动障碍患者在脑卒中早期康复中的现代康复技术(综述)。
IF 0.6 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 DOI: 10.17691/stm2022.14.6.07
A E Khrulev, K M Kuryatnikova, А N Belova, P S Popova, S Е Khrulev

Cerebral stroke is one of the leading disability causes among adult population worldwide. The number of post-stroke patients, who need rehabilitation including motor recovery, keeps growing annually. Standard motor rehabilitation techniques have a limited effect on recovering extremity motor defunctionalization. In this regard, in recent years, new technologies of post-stroke rehabilitation are being suggested. The present review summarizes the existing literature data on current techniques applied in patients with motor disorders at an early rehabilitation period of cerebral stroke. The current modern technologies are divided into the methods based on "interhemispheric inhibition" theory (repetitive transcranial magnetic stimulation, transcranial direct current stimulation), and on "mirror neurons" theory (virtual reality systems and brain-computer interfaces). The authors present the neurophysiological causes and feasible protocols of using the techniques in clinical practice, the clinical research findings due to the initial severity level of motor disorders and stroke age, as well as the factors contributing to the motor rehabilitation efficiency when using these methods.

脑卒中是全球成年人致残的主要原因之一。需要包括运动恢复在内的康复治疗的脑卒中后患者数量逐年增加。标准的运动康复技术对四肢运动功能失能的恢复效果有限。在这方面,近年来,脑卒中后康复的新技术不断被提出。本文综述了脑卒中早期康复期运动障碍治疗技术的文献资料。目前的现代技术分为基于“半球间抑制”理论(重复经颅磁刺激、经颅直流电刺激)和基于“镜像神经元”理论(虚拟现实系统和脑机接口)的方法。作者介绍了在临床上应用该技术的神经生理学原因和可行方案,由于运动障碍的初始严重程度和中风年龄而引起的临床研究结果,以及使用这些方法时影响运动康复效率的因素。
{"title":"Modern Rehabilitation Technologies of Patients with Motor Disorders at an Early Rehabilitation of Stroke (Review).","authors":"A E Khrulev,&nbsp;K M Kuryatnikova,&nbsp;А N Belova,&nbsp;P S Popova,&nbsp;S Е Khrulev","doi":"10.17691/stm2022.14.6.07","DOIUrl":"https://doi.org/10.17691/stm2022.14.6.07","url":null,"abstract":"<p><p>Cerebral stroke is one of the leading disability causes among adult population worldwide. The number of post-stroke patients, who need rehabilitation including motor recovery, keeps growing annually. Standard motor rehabilitation techniques have a limited effect on recovering extremity motor defunctionalization. In this regard, in recent years, new technologies of post-stroke rehabilitation are being suggested. The present review summarizes the existing literature data on current techniques applied in patients with motor disorders at an early rehabilitation period of cerebral stroke. The current modern technologies are divided into the methods based on \"interhemispheric inhibition\" theory (repetitive transcranial magnetic stimulation, transcranial direct current stimulation), and on \"mirror neurons\" theory (virtual reality systems and brain-computer interfaces). The authors present the neurophysiological causes and feasible protocols of using the techniques in clinical practice, the clinical research findings due to the initial severity level of motor disorders and stroke age, as well as the factors contributing to the motor rehabilitation efficiency when using these methods.</p>","PeriodicalId":51886,"journal":{"name":"Sovremennye Tehnologii v Medicine","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171053/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9681406","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Integral and Local Methods for the Evaluation of the Hemostasiological Profile in Sheep at Various Stages of Implantation of a Biodegradable Vascular Graft. 生物可降解血管移植不同阶段绵羊止血特征的整体和局部评价方法。
IF 0.6 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 DOI: 10.17691/stm2022.14.5.03
O V Gruzdeva, E E Bychkova, T Yu Penskaya, A A Kuzmina, L V Antonova, L S Barbarash

The aim of this study was to evaluate the efficiency of local and integral methods of the assessment of the hemostasiological profile in sheep at various stages of implantation of a biodegradable vascular graft.

Materials and methods: The object of the study was the whole blood of sheep collected at the stage of premedication, during the intraoperative period, and in the early postoperative period. Thromboelastography was used to assess the kinetics of clot formation and changes in its viscoelastic properties in whole blood samples. The thrombin generation test was performed in platelet-rich plasma (PRP) and platelet-poor plasma (PPP) with the assessment of quantitative and temporal parameters. The platelet factor 4 concentration in PRP and PPP was measured by the enzyme immunoassay. The functional activity of platelets in PPP was assessed with inductors and without additional stimulation. Prothrombin complex activity, APTT values, thrombin time, fibrinogen concentration, antithrombin III and protein C activity, soluble fibrin monomer complexes, and fibrinolysis were determined in blood plasma.

Results: Multidirectional changes in the hemostasiological profile at various stages of vascular prosthesis implantation have been revealed. On the one hand, it is an increased prothrombogenic status, on the other hand, it is the development of hypocoagulation. Shortening of the R (blood coagulation time) and K (clot formation time) intervals and an increase in the angle parameter and maximum amplitude on the thromboelastogram in all the studied periods relative to the reference values, a significant increase in platelet factor 4 in PRP and increased platelet aggregation testified in favor of hypercoagulation. However, the quantitative parameters of the thrombin generation test and a number of coagulogram indicators pointed to hypocoagulation in the intraoperative and early postoperative periods.

Conclusion: The comparative analysis of local tests characterizing the state of hemostasis and indicators of integral methods demonstrated the advantages of the latter in assessing thrombotic risks during implantation of vascular grafts. Local tests are not sufficient to assess the dynamics of the coagulation process in real time and are not always sensitive to hypercoagulation. The use of integral methods will help to fill these gaps, make a timely diagnosis of hypercoagulability and minimize the risks associated with the implantation of vascular grafts in future.

本研究的目的是评估在植入可生物降解血管移植物的不同阶段评估绵羊止血情况的局部和整体方法的效率。材料与方法:研究对象为术前、术中、术后早期采集的绵羊全血。血栓弹性成像是用来评估动力学的凝块形成和其粘弹性性质的变化在全血样本。在富血小板血浆(PRP)和贫血小板血浆(PPP)中进行凝血酶生成试验,并评估定量和时间参数。采用酶免疫法测定血小板因子4在PRP和PPP中的浓度。在没有额外刺激的情况下,使用诱导剂评估PPP患者血小板的功能活性。测定血浆中凝血酶原复合物活性、APTT值、凝血酶时间、纤维蛋白原浓度、抗凝血酶III和蛋白C活性、可溶性纤维蛋白单体复合物和纤维蛋白溶解。结果:血管假体植入术不同阶段止血谱的多向变化。一方面是血栓形成前状态增高,另一方面是低凝的发展。各研究时段凝血时间R和凝块形成时间K间隔较参考值缩短,血栓弹性图角度参数和最大振幅增大,PRP中血小板因子4显著升高,血小板聚集增加,均有利于高凝。但凝血酶生成试验的定量参数及多项凝血图指标均提示术中及术后早期存在低凝。结论:局部止血指标与综合止血指标的对比分析表明,综合止血指标在评估血管植入过程中血栓形成风险方面具有优势。局部试验不足以实时评估凝血过程的动态,并且对高凝并不总是敏感的。综合方法的使用将有助于填补这些空白,及时诊断高凝性,并将未来血管移植的相关风险降至最低。
{"title":"Integral and Local Methods for the Evaluation of the Hemostasiological Profile in Sheep at Various Stages of Implantation of a Biodegradable Vascular Graft.","authors":"O V Gruzdeva,&nbsp;E E Bychkova,&nbsp;T Yu Penskaya,&nbsp;A A Kuzmina,&nbsp;L V Antonova,&nbsp;L S Barbarash","doi":"10.17691/stm2022.14.5.03","DOIUrl":"https://doi.org/10.17691/stm2022.14.5.03","url":null,"abstract":"<p><p><b>The aim of this study</b> was to evaluate the efficiency of local and integral methods of the assessment of the hemostasiological profile in sheep at various stages of implantation of a biodegradable vascular graft.</p><p><strong>Materials and methods: </strong>The object of the study was the whole blood of sheep collected at the stage of premedication, during the intraoperative period, and in the early postoperative period. Thromboelastography was used to assess the kinetics of clot formation and changes in its viscoelastic properties in whole blood samples. The thrombin generation test was performed in platelet-rich plasma (PRP) and platelet-poor plasma (PPP) with the assessment of quantitative and temporal parameters. The platelet factor 4 concentration in PRP and PPP was measured by the enzyme immunoassay. The functional activity of platelets in PPP was assessed with inductors and without additional stimulation. Prothrombin complex activity, APTT values, thrombin time, fibrinogen concentration, antithrombin III and protein C activity, soluble fibrin monomer complexes, and fibrinolysis were determined in blood plasma.</p><p><strong>Results: </strong>Multidirectional changes in the hemostasiological profile at various stages of vascular prosthesis implantation have been revealed. On the one hand, it is an increased prothrombogenic status, on the other hand, it is the development of hypocoagulation. Shortening of the <i>R</i> (blood coagulation time) and <i>K</i> (clot formation time) intervals and an increase in the angle parameter and maximum amplitude on the thromboelastogram in all the studied periods relative to the reference values, a significant increase in platelet factor 4 in PRP and increased platelet aggregation testified in favor of hypercoagulation. However, the quantitative parameters of the thrombin generation test and a number of coagulogram indicators pointed to hypocoagulation in the intraoperative and early postoperative periods.</p><p><strong>Conclusion: </strong>The comparative analysis of local tests characterizing the state of hemostasis and indicators of integral methods demonstrated the advantages of the latter in assessing thrombotic risks during implantation of vascular grafts. Local tests are not sufficient to assess the dynamics of the coagulation process in real time and are not always sensitive to hypercoagulation. The use of integral methods will help to fill these gaps, make a timely diagnosis of hypercoagulability and minimize the risks associated with the implantation of vascular grafts in future.</p>","PeriodicalId":51886,"journal":{"name":"Sovremennye Tehnologii v Medicine","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10171058/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9681408","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interstitial Glucose Metabolism Monitoring as an Additional Method for Objective Assessment of Donor Liver, Prediction and Immediate Diagnosis of Early Graft Dysfunction. 间质糖代谢监测作为客观评估供肝、早期移植物功能障碍预测和即时诊断的附加方法。
IF 0.6 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 DOI: 10.17691/stm2022.14.3.04
A I Sushkov, S E Voskanyan, V S Rudakov, M V Popov, K K Gubarev, D S Svetlakova, A I Artemiev

The current clinical practice of assessing the quality and suitability of a donor liver for human transplantation does not exclude cases of primary graft dysfunction of the transplanted organ and, at the same time, leads to an unreasonable refusal to transplant a significant number of functionally suitable organs. In this regard, searching for new methods for additional objective assessment and monitoring of the state of donor organs in the peritransplant period is relevant. The aim of the study was to determine the clinical utility of monitoring interstitial concentrations of glucose and its metabolites to assess the viability and functional state of a donor liver before and after human transplantation.

Materials and methods: A retrospective observational single-center study included 32 cases of liver transplantation. Along with standard methods for assessing the initial function of grafts during the first week after surgery, interstitial (in the transplanted liver) concentrations of glucose and its metabolites were monitored. In 18 cases, the interstitial glucose metabolism was also studied during static cold storage (SCS).

Results: With the development of early allograft dysfunction (EAD), compared with the uneventful post-transplant period, statistically significantly higher interstitial lactate concentrations were observed as early as 3 h after reperfusion: 12.3 [10.1; 15.6] mmol/L versus 7.2 [3.9; 9.9] mmol/L (p=0.003). A value above 8.8 mmol/L may be considered as a criterion for the immediate diagnosis of EAD (sensitivity - 89%, specificity - 65%).Interstitial lactate concentration at the end of SCS and the area under the "lactate concentration-SCS duration" curve were associated with the initial graft function. Values of these parameters greater than 15.4 mmol/L and 76.1 mmol/L·h, respectively, with a sensitivity of 100% in both cases and a specificity of 77 and 85%, may be used to assess the risk of primary EAD.

Conclusion: Monitoring of interstitial concentrations of glucose and its metabolites, primarily, lactate, is an objective additional method for the assessment of the donor liver viability both during SCS and in the early postoperative period.

目前评估供肝的质量和适宜性用于人体移植的临床实践并没有排除移植器官原发性移植物功能障碍的情况,同时,导致大量功能合适的器官被不合理地拒绝移植。在这方面,寻找新的方法来进一步客观评估和监测供体器官在移植期的状态是相关的。该研究的目的是确定监测间质葡萄糖及其代谢物浓度的临床应用,以评估人体移植前后供体肝脏的活力和功能状态。材料与方法:回顾性观察性单中心研究纳入32例肝移植。在术后第一周内,与评估移植物初始功能的标准方法一起,监测间质(移植肝脏)葡萄糖及其代谢物的浓度。在静态冷藏(SCS)期间,对18例间质糖代谢进行了研究。结果:随着早期同种异体移植物功能障碍(EAD)的发展,与移植后平稳期相比,早在再灌注后3 h间质乳酸浓度就有统计学意义上的升高:12.3 [10.1;15.6] mmol/L vs . 7.2 [3.9;9.9] mmol/L (p=0.003)。高于8.8 mmol/L可作为立即诊断EAD的标准(敏感性89%,特异性65%)。SCS末端间质乳酸浓度和“乳酸浓度-SCS持续时间”曲线下面积与初始移植物功能相关。这些参数值分别大于15.4 mmol/L和76.1 mmol/L·h,敏感性均为100%,特异性分别为77%和85%,可用于评估原发性EAD的风险。结论:监测间质葡萄糖及其代谢物(主要是乳酸)浓度是评估SCS期间和术后早期供肝活力的一种客观的附加方法。
{"title":"Interstitial Glucose Metabolism Monitoring as an Additional Method for Objective Assessment of Donor Liver, Prediction and Immediate Diagnosis of Early Graft Dysfunction.","authors":"A I Sushkov,&nbsp;S E Voskanyan,&nbsp;V S Rudakov,&nbsp;M V Popov,&nbsp;K K Gubarev,&nbsp;D S Svetlakova,&nbsp;A I Artemiev","doi":"10.17691/stm2022.14.3.04","DOIUrl":"https://doi.org/10.17691/stm2022.14.3.04","url":null,"abstract":"<p><p>The current clinical practice of assessing the quality and suitability of a donor liver for human transplantation does not exclude cases of primary graft dysfunction of the transplanted organ and, at the same time, leads to an unreasonable refusal to transplant a significant number of functionally suitable organs. In this regard, searching for new methods for additional objective assessment and monitoring of the state of donor organs in the peritransplant period is relevant. <b>The aim of the study</b> was to determine the clinical utility of monitoring interstitial concentrations of glucose and its metabolites to assess the viability and functional state of a donor liver before and after human transplantation.</p><p><strong>Materials and methods: </strong>A retrospective observational single-center study included 32 cases of liver transplantation. Along with standard methods for assessing the initial function of grafts during the first week after surgery, interstitial (in the transplanted liver) concentrations of glucose and its metabolites were monitored. In 18 cases, the interstitial glucose metabolism was also studied during static cold storage (SCS).</p><p><strong>Results: </strong>With the development of early allograft dysfunction (EAD), compared with the uneventful post-transplant period, statistically significantly higher interstitial lactate concentrations were observed as early as 3 h after reperfusion: 12.3 [10.1; 15.6] mmol/L versus 7.2 [3.9; 9.9] mmol/L (p=0.003). A value above 8.8 mmol/L may be considered as a criterion for the immediate diagnosis of EAD (sensitivity - 89%, specificity - 65%).Interstitial lactate concentration at the end of SCS and the area under the \"lactate concentration-SCS duration\" curve were associated with the initial graft function. Values of these parameters greater than 15.4 mmol/L and 76.1 mmol/L·h, respectively, with a sensitivity of 100% in both cases and a specificity of 77 and 85%, may be used to assess the risk of primary EAD.</p><p><strong>Conclusion: </strong>Monitoring of interstitial concentrations of glucose and its metabolites, primarily, lactate, is an objective additional method for the assessment of the donor liver viability both during SCS and in the early postoperative period.</p>","PeriodicalId":51886,"journal":{"name":"Sovremennye Tehnologii v Medicine","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090915/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9686900","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Chronic Critical Illness: Current Aspects of the Problem (Review). 慢性危重疾病:问题的当前方面(回顾)。
IF 0.6 Q3 Biochemistry, Genetics and Molecular Biology Pub Date : 2022-01-01 DOI: 10.17691/stm2022.14.3.08
A L Parfenov, V P Razzhivin, M V Petrova

Chronic resuscitation patients who have survived the acute phase of a disease represent a fast-growing cohort of patients requiring specialized medical assistant in intensive care and resuscitation units (ICRU) for several months or years. The term "chronic critical illness" (CCI) was proposed for such patients in the mid-80s of the last century. Patients with CCI make up from 5 to 20% of ICRU. Over time, they develop homeostasis disorders resulting in multiple organ failure and death. Mortality in CCI exceeds that of the majority of malignant neoplasms and functional dependence remains in most of survivors. In the present review, the attempt is made to show the main links of CCI pathogenesis which, if acted upon, can prevent unfavorable outcome. The publications describing epidemiology of CCI, its outcomes, and clinical phenotype have been analyzed. Several researchers consider CCI as a result of persistent inflammation, immunosuppression, and catabolism syndrome. Some works show the importance of nutrition for ICRU patients. The role of gastrointestinal tract in CCI formation has been noted. The effect of intensive therapy on microbiota of the ICRU patients has been demonstrated. Microbiome disturbances in dysbiosis and sepsis have been considered, as well as the effect of intestinal microbiome on the distant organs. Post-intensive care syndrome is a significant constituent of CCI. The main sequelae of the syndrome, as well as the general questions of its prevention and treatment, have been denoted.

在疾病急性期存活下来的慢性复苏患者是一个快速增长的群体,需要在重症监护和复苏病房(ICRU)提供数月或数年的专业医疗助理。“慢性危重症”(CCI)一词是在上世纪80年代中期提出的。CCI患者占ICRU的5%至20%。随着时间的推移,他们会发展出体内平衡失调,导致多器官衰竭和死亡。CCI的死亡率超过大多数恶性肿瘤,大多数幸存者仍然存在功能依赖。在目前的回顾中,试图表明CCI发病机制的主要环节,如果采取行动,可以预防不良后果。对描述CCI流行病学、结果和临床表型的出版物进行了分析。一些研究人员认为CCI是持续炎症、免疫抑制和分解代谢综合征的结果。一些研究表明营养对ICRU患者的重要性。胃肠道在CCI形成中的作用已被注意到。强化治疗对ICRU患者微生物群的影响已得到证实。微生物组紊乱在生态失调和败血症中被考虑,以及肠道微生物组对远处器官的影响。重症监护后综合征是CCI的重要组成部分。文中指出了该综合征的主要后遗症,以及预防和治疗的一般问题。
{"title":"Chronic Critical Illness: Current Aspects of the Problem (Review).","authors":"A L Parfenov,&nbsp;V P Razzhivin,&nbsp;M V Petrova","doi":"10.17691/stm2022.14.3.08","DOIUrl":"https://doi.org/10.17691/stm2022.14.3.08","url":null,"abstract":"<p><p>Chronic resuscitation patients who have survived the acute phase of a disease represent a fast-growing cohort of patients requiring specialized medical assistant in intensive care and resuscitation units (ICRU) for several months or years. The term \"chronic critical illness\" (CCI) was proposed for such patients in the mid-80s of the last century. Patients with CCI make up from 5 to 20% of ICRU. Over time, they develop homeostasis disorders resulting in multiple organ failure and death. Mortality in CCI exceeds that of the majority of malignant neoplasms and functional dependence remains in most of survivors. In the present review, the attempt is made to show the main links of CCI pathogenesis which, if acted upon, can prevent unfavorable outcome. The publications describing epidemiology of CCI, its outcomes, and clinical phenotype have been analyzed. Several researchers consider CCI as a result of persistent inflammation, immunosuppression, and catabolism syndrome. Some works show the importance of nutrition for ICRU patients. The role of gastrointestinal tract in CCI formation has been noted. The effect of intensive therapy on microbiota of the ICRU patients has been demonstrated. Microbiome disturbances in dysbiosis and sepsis have been considered, as well as the effect of intestinal microbiome on the distant organs. Post-intensive care syndrome is a significant constituent of CCI. The main sequelae of the syndrome, as well as the general questions of its prevention and treatment, have been denoted.</p>","PeriodicalId":51886,"journal":{"name":"Sovremennye Tehnologii v Medicine","volume":null,"pages":null},"PeriodicalIF":0.6,"publicationDate":"2022-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10090919/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9686903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
期刊
Sovremennye Tehnologii v Medicine
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1